Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-107109
Filing Date
2013-03-14
Accepted
2013-03-14 14:38:28
Documents
15
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d444058d10k.htm 10-K 1370185
2 EX-21.1 d444058dex211.htm EX-21.1 1734
3 EX-23.1 d444058dex231.htm EX-23.1 1644
4 EX-31.1 d444058dex311.htm EX-31.1 6180
5 EX-31.2 d444058dex312.htm EX-31.2 6152
6 EX-32.1 d444058dex321.htm EX-32.1 4104
7 EX-32.2 d444058dex322.htm EX-32.2 4064
14 GRAPHIC g444058g19u98.jpg GRAPHIC 68813
15 GRAPHIC g444058g50u14.jpg GRAPHIC 60203
  Complete submission text file 0001193125-13-107109.txt   8461604

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ccxi-20121231.xml EX-101.INS 1187459
9 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20121231.xsd EX-101.SCH 63358
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20121231_cal.xml EX-101.CAL 78808
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20121231_def.xml EX-101.DEF 302911
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20121231_lab.xml EX-101.LAB 513725
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20121231_pre.xml EX-101.PRE 418338
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35420 | Film No.: 13690141
SIC: 2834 Pharmaceutical Preparations